We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | NYSE:TMO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 574.99 | 43 | 13:01:44 |
From May 2022 to May 2024
By Dean Seal
Thermo Fisher Scientific Inc. expects revenue to grow by less than 1% this year.
The scientific-equipment company said Wednesday that it is forecasting revenue of $45.3 billion in 2023, up from $44.92 billion last year. The 2022 figure marked a 15% jump from the year prior.
Core organic revenue, which includes the impact of revenue from clinical research services provider PPD and excludes the impact of all other acquisitions as well as Covid-19 testing revenue, is expected to grow by 7%.
Adjusted earnings for the year are projected to be $23.70 a share, the company said.
Shares edged less than 1% higher to $575 in premarket trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 01, 2023 07:03 ET (12:03 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Thermo Fisher Scientific Chart |
1 Month Thermo Fisher Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
